US Patent 10995336 Serpina1 iRNA compositions and methods of use thereof
Patent 10995336 was granted and assigned to Alnylam Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10995336 Serpina1 iRNA compositions and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
